drugset
drugset / Trial / NCT05654233

The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy

NCT05654233 ↗

Unknown 120 enrolled Chengdu University of Traditional Chinese Medicine
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate whether adding sulodexide to the patients with varicose veins who received radiofrequency ablation combined with sclerotherapy can reduce or improve the impact of adverse events。

Timeline

Start
2023-02-01
Primary completion
2023-08-01
Completion
2023-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sulodexide Other / unclassified 250 unknown Oral

Indications

chronic venous insufficiency peripheral vascular disease varicose disease